Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Rovner

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Lower Urinary Tract Symptoms|March 2, 2022
Does urinary urgency drive urinary frequency in overactive bladder?Eboo Versi, Eric S Rovner, Roger R Dmochowski, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 24, 2012
SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscleRupal P Soder, Shankar P Parajuli, Kiril L Hristov, et al.
Plos One|March 19, 2021
Severe urinary tract damage secondary to primary bladder neck obstruction in womenPedro F S Freitas, Augusto Q Coelho, Homero Bruschini, et al.
BJU International|April 29, 2006
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinenceClaus G Roehrborn, Paul Abrams, Eric S Rovner, et al.
JAMA|November 16, 2006
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trialSteven A Kaplan, Claus G Roehrborn, Eric S Rovner, et al.
Revista Do Hospital Das Clinicas|August 10, 2002
Evaluation and treatment of the overactive bladderEric S Rovner, Cristiano M Gomes, Flavio E Trigo-Rocha, et al.
Urology|September 3, 2025
Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE TrialKenneth M Peters, Janet Owens-Grillo, Elizabeth Thomas, et al.
American Journal of Physiology. Renal Physiology|February 26, 2016
BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle functionWenkuan Xin, Ning Li, Vitor S Fernandes, et al.
Urology|August 15, 2006
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturiaSteven A Kaplan, Claus G Roehrborn, Roger Dmochowski, et al.
Urology|April 16, 2016
Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant?Nima Baradaran, Leah R Chiles, Drew A Freilich, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Lower Urinary Tract Symptoms|March 2, 2022
Does urinary urgency drive urinary frequency in overactive bladder?Eboo Versi, Eric S Rovner, Roger R Dmochowski, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 24, 2012
SK channel-selective opening by SKA-31 induces hyperpolarization and decreases contractility in human urinary bladder smooth muscleRupal P Soder, Shankar P Parajuli, Kiril L Hristov, et al.
Plos One|March 19, 2021
Severe urinary tract damage secondary to primary bladder neck obstruction in womenPedro F S Freitas, Augusto Q Coelho, Homero Bruschini, et al.
BJU International|April 29, 2006
Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinenceClaus G Roehrborn, Paul Abrams, Eric S Rovner, et al.
JAMA|November 16, 2006
Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trialSteven A Kaplan, Claus G Roehrborn, Eric S Rovner, et al.
Revista Do Hospital Das Clinicas|August 10, 2002
Evaluation and treatment of the overactive bladderEric S Rovner, Cristiano M Gomes, Flavio E Trigo-Rocha, et al.
Urology|September 3, 2025
Clinically Meaningful Improvements With Vibegron in Men With Overactive Bladder and Benign Prostatic Hyperplasia: A Responder Analysis of the Phase 3 COURAGE TrialKenneth M Peters, Janet Owens-Grillo, Elizabeth Thomas, et al.
American Journal of Physiology. Renal Physiology|February 26, 2016
BK channel regulation by phosphodiesterase type 1: a novel signaling pathway controlling human detrusor smooth muscle functionWenkuan Xin, Ning Li, Vitor S Fernandes, et al.
Urology|August 15, 2006
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturiaSteven A Kaplan, Claus G Roehrborn, Roger Dmochowski, et al.
Urology|April 16, 2016
Female Urethral Diverticula in the Contemporary Era: Is the Classic Triad of the "3Ds" Still Relevant?Nima Baradaran, Leah R Chiles, Drew A Freilich, et al.
Pageof 11